Chordate Medical
Chordate Medical, headquartered in Sweden, is a pioneering company in the medical technology industry, specialising in innovative treatments for chronic nasal conditions. Founded in 2011, Chordate has made significant strides with its flagship product, the K.O.S. (Kinetic Oscillation Stimulation) device, which offers a non-invasive solution for patients suffering from conditions such as rhinitis and sinusitis. With a strong presence in Europe and expanding operations in other regions, Chordate Medical is recognised for its commitment to enhancing patient quality of life through advanced therapeutic options. The company has achieved notable milestones, including successful clinical trials and regulatory approvals, solidifying its position as a leader in the field. Chordate's unique approach combines cutting-edge technology with a patient-centric focus, setting it apart in the competitive landscape of medical devices.
DitchCarbon Score
How does Chordate Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Chordate Medical's score of 6 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Chordate Medical's reported carbon emissions
Chordate Medical, headquartered in Sweden (SE), currently does not have any publicly available carbon emissions data for recent years. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not disclosed. In the absence of emissions data, it is important to note that Chordate Medical has not outlined any specific reduction targets or climate commitments. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability and carbon neutrality, it will be essential for Chordate Medical to establish clear climate commitments and reduction initiatives to align with global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Chordate Medical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
